SPORTS Nigerian sprinter Okagbare suspended for doping before Tokyo 2020 race


Nigerian sprinter Okagbare suspended for doping before Tokyo 2020 race


13:48, July 31, 2021

Blessing Okagbare, of Nigeria, wins a heat in the women's 100-meter run at the 2020 Summer Olympics, Friday, July 30, 2021, in Tokyo. (Photo: AP)

TOKYO, July 31 (Xinhua) -- Nigerian sprinter Blessing Okagbare has been banned from the women's 100m semifinal at the Tokyo Olympics after an out-of-competition doping test returned positive result.

The Athletics Integrity Unit (AIU) said it has provisionally suspended Okagbare with immediate effect after a sample collected from the sprinter tested positive for human growth hormone.

The AIU collected the sample from Okagbare during an out-of-competition test on July 19 and was notified of the positive result by the WADA-accredited laboratory that analyzed the sample at mid-day Central European Time on Friday, said the independent body created by the World Athletics that manages all integrity issues, including doping for athletics.

Under doping regulations, Okagbare is allowed to request a test on her "B" sample to confirm the results.

Growth Hormone is a non-specified substance on the 2021 World Anti-Doping Agency (WADA) Prohibited List and a provisional suspension is mandatory following an adverse analytical finding for such substance under the World Athletics Anti-Doping Rules, the AIU said in a statement.

AIU said the Okagbare was notified of the adverse analytical finding and of her provisional suspension Saturday morning in Tokyo, where she has qualified for the women's 100m semifinals scheduled later in the evening after winning her 100m heat on Friday.

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue